Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
PharmaVOICE recently featured Gadi Saarony, CEO at Advarra, in its cover article “A New Era of Clinical Trials” discussing how the research industry’s response to the COVID-19 pandemic “will set…
Throughout the COVID-19 pandemic, we have continually heard what the “new normal” could mean for our work lives, social lives, schools, communities, and our medical system. But what does it…
The global pandemic has changed the way we think about research. Sponsors should consider how the “new normal” will impact sites and current studies as they plan to re-start research.
The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized to the proposed research as well as the existing facility and local regulatory requirements.